These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1812 related items for PubMed ID: 19302899

  • 1. Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active- and placebo-controlled study.
    Hartrick C, Van Hove I, Stegmann JU, Oh C, Upmalis D.
    Clin Ther; 2009 Feb; 31(2):260-71. PubMed ID: 19302899
    [Abstract] [Full Text] [Related]

  • 2. A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain.
    Daniels S, Casson E, Stegmann JU, Oh C, Okamoto A, Rauschkolb C, Upmalis D.
    Curr Med Res Opin; 2009 Jun; 25(6):1551-61. PubMed ID: 19445652
    [Abstract] [Full Text] [Related]

  • 3. Comparable efficacy and superior gastrointestinal tolerability (nausea, vomiting, constipation) of tapentadol compared with oxycodone hydrochloride.
    Etropolski M, Kelly K, Okamoto A, Rauschkolb C.
    Adv Ther; 2011 May; 28(5):401-17. PubMed ID: 21494892
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial.
    Aqua K, Gimbel JS, Singla N, Ma T, Ahdieh H, Kerwin R.
    Clin Ther; 2007 Jun; 29(6):1000-12. PubMed ID: 17692717
    [Abstract] [Full Text] [Related]

  • 5. Tapentadol immediate release versus oxycodone immediate release for treatment of acute low back pain.
    Biondi D, Xiang J, Benson C, Etropolski M, Moskovitz B, Rauschkolb C.
    Pain Physician; 2013 Jun; 16(3):E237-46. PubMed ID: 23703422
    [Abstract] [Full Text] [Related]

  • 6. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A, Ma C, Ahdieh H, Galer BS.
    Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of sustained-release tramadol in the treatment of symptomatic osteoarthritis of the hip or knee: a multicenter, randomized, double-blind, placebo-controlled study.
    Malonne H, Coffiner M, Sonet B, Sereno A, Vanderbist F.
    Clin Ther; 2004 Nov; 26(11):1774-82. PubMed ID: 15639689
    [Abstract] [Full Text] [Related]

  • 8. Analgesic efficacy and tolerability of oxycodone 5 mg/ibuprofen 400 mg compared with those of oxycodone 5 mg/acetaminophen 325 mg and hydrocodone 7.5 mg/acetaminophen 500 mg in patients with moderate to severe postoperative pain: a randomized, double-blind, placebo-controlled, single-dose, parallel-group study in a dental pain model.
    Litkowski LJ, Christensen SE, Adamson DN, Van Dyke T, Han SH, Newman KB.
    Clin Ther; 2005 Apr; 27(4):418-29. PubMed ID: 15922815
    [Abstract] [Full Text] [Related]

  • 9. Single dose analgesic efficacy of tapentadol in postsurgical dental pain: the results of a randomized, double-blind, placebo-controlled study.
    Kleinert R, Lange C, Steup A, Black P, Goldberg J, Desjardins P.
    Anesth Analg; 2008 Dec; 107(6):2048-55. PubMed ID: 19020157
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study.
    Buynak R, Shapiro DY, Okamoto A, Van Hove I, Rauschkolb C, Steup A, Lange B, Lange C, Etropolski M.
    Expert Opin Pharmacother; 2010 Aug; 11(11):1787-804. PubMed ID: 20578811
    [Abstract] [Full Text] [Related]

  • 11. Combination oxycodone 5 mg/ibuprofen 400 mg for the treatment of pain after abdominal or pelvic surgery in women: a randomized, double-blind, placebo- and active-controlled parallel-group study.
    Singla N, Pong A, Newman K, MD-10 Study Group.
    Clin Ther; 2005 Jan; 27(1):45-57. PubMed ID: 15763605
    [Abstract] [Full Text] [Related]

  • 12. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM, Messina J, Xie F, Hale M.
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [Abstract] [Full Text] [Related]

  • 13. Diclofenac potassium liquid-filled soft gelatin capsules in the management of patients with postbunionectomy pain: a Phase III, multicenter, randomized, double-blind, placebo-controlled study conducted over 5 days.
    Riff DS, Duckor S, Gottlieb I, Diamond E, Soulier S, Raymond G, Boesing SE.
    Clin Ther; 2009 Oct; 31(10):2072-85. PubMed ID: 19922878
    [Abstract] [Full Text] [Related]

  • 14. Post hoc analyses of data from a 90-day clinical trial evaluating the tolerability and efficacy of tapentadol immediate release and oxycodone immediate release for the relief of moderate to severe pain in elderly and nonelderly patients.
    Vorsanger G, Xiang J, Biondi D, Upmalis D, Delfgaauw J, Allard R, Moskovitz B.
    Pain Res Manag; 2011 Oct; 16(4):245-51. PubMed ID: 22059194
    [Abstract] [Full Text] [Related]

  • 15. A randomized, double-blind, phase III study comparing multiple doses of tapentadol IR, oxycodone IR, and placebo for postoperative (bunionectomy) pain.
    Daniels SE, Upmalis D, Okamoto A, Lange C, Häeussler J.
    Curr Med Res Opin; 2009 Mar; 25(3):765-76. PubMed ID: 19203298
    [Abstract] [Full Text] [Related]

  • 16. Tolerability of tapentadol immediate release in patients with lower back pain or osteoarthritis of the hip or knee over 90 days: a randomized, double-blind study.
    Hale M, Upmalis D, Okamoto A, Lange C, Rauschkolb C.
    Curr Med Res Opin; 2009 May; 25(5):1095-104. PubMed ID: 19301989
    [Abstract] [Full Text] [Related]

  • 17. Immediate-release tapentadol or oxycodone for treatment of acute postoperative pain after elective arthroscopic shoulder surgery: a randomized, phase IIIb study.
    Vorsanger GJ, Klopfer AM, Xiang J, Benson CJ, Moskovitz BL, Rosenthal NR.
    J Opioid Manag; 2013 May; 9(4):281-90. PubMed ID: 24353022
    [Abstract] [Full Text] [Related]

  • 18. Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study.
    Sorge J, Sittl R.
    Clin Ther; 2004 Nov; 26(11):1808-20. PubMed ID: 15639693
    [Abstract] [Full Text] [Related]

  • 19. Oxymorphone extended-release tablets relieve moderate to severe pain and improve physical function in osteoarthritis: results of a randomized, double-blind, placebo- and active-controlled phase III trial.
    Matsumoto AK, Babul N, Ahdieh H.
    Pain Med; 2005 Nov; 6(5):357-66. PubMed ID: 16266356
    [Abstract] [Full Text] [Related]

  • 20. Pain relief and tolerability balance of immediate release tapentadol or oxycodone treatment for patients with moderate to severe osteoarthritis or low back pain.
    Kavanagh S, Kwong WJ, Hammond GC, Nelson W, Upmalis D, Yang M.
    Pain Med; 2012 Sep; 13(9):1110-20. PubMed ID: 22845494
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 91.